FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016895314> ?p ?o ?g. }

• W2016895314 endingPage "951" @default.
• W2016895314 startingPage "946" @default.
• W2016895314 abstract "To report a new syndrome of ascites, hyperbilirubinemia, and hypoalbuminemia after treatment with N-phosphonacetyl-L-aspartate (PALA) and fluorouracil for metastatic colorectal cancer.Retrospective analysis.Regional cancer treatment center.Forty-four previously untreated patients with metastatic colorectal cancer in a phase I-II trial of PALA-fluorouracil.One or more transient hepatic abnormalities frequently occurred in 15 of the 17 responding patients. Within the first 10 weeks of treatment, 5 patients developed ascites, 12 had a decrease in the serum albumin level, 6 developed bilirubin elevations, and 7 had transaminase elevations, all in the presence of a complete or partial tumor response. Prolongations of the prothrombin time and elevations of serum glucose levels were also seen.An unusual syndrome of ascites, hyperbilirubinemia, and hypoalbuminemia is associated with a PALA-fluorouracil regimen. These abnormalities, which may be related to decreased hepatic protein synthesis, occurred more often in patients whose tumor was responding to chemotherapy. Clinicians must recognize that in patients undergoing chemotherapy with these agents, ascites and elevated liver function tests may be secondary to drug administration and are not necessarily due to disease progression." @default.
• W2016895314 created "2016-06-24" @default.
• W2016895314 creator A5024202625 @default.
• W2016895314 creator A5032053177 @default.
• W2016895314 creator A5060223419 @default.
• W2016895314 creator A5062950311 @default.
• W2016895314 creator A5069644669 @default.
• W2016895314 creator A5073130519 @default.
• W2016895314 creator A5084409602 @default.
• W2016895314 creator A5089633724 @default.
• W2016895314 date "1991-12-15" @default.
• W2016895314 modified "2023-09-26" @default.
• W2016895314 title "A New Syndrome: Ascites, Hyperbilirubinemia, and Hypoalbuminemia after Biochemical Modulation of Fluorouracil with N-Phosphonacetyl-L-Aspartate (PALA)" @default.
• W2016895314 cites W1532113135 @default.
• W2016895314 cites W1561167748 @default.
• W2016895314 cites W156275343 @default.
• W2016895314 cites W173489377 @default.
• W2016895314 cites W1916504364 @default.
• W2016895314 cites W1964768968 @default.
• W2016895314 cites W1971609285 @default.
• W2016895314 cites W1972465013 @default.
• W2016895314 cites W1978665378 @default.
• W2016895314 cites W1994862441 @default.
• W2016895314 cites W2011032452 @default.
• W2016895314 cites W2049266649 @default.
• W2016895314 cites W2053435659 @default.
• W2016895314 cites W2055968604 @default.
• W2016895314 cites W2057297505 @default.
• W2016895314 cites W2088041688 @default.
• W2016895314 cites W2243361793 @default.
• W2016895314 cites W2257660895 @default.
• W2016895314 cites W2258295221 @default.
• W2016895314 cites W2271306081 @default.
• W2016895314 cites W4206261143 @default.
• W2016895314 cites W4230372598 @default.
• W2016895314 cites W4253830259 @default.
• W2016895314 cites W2039327023 @default.
• W2016895314 doi "https://doi.org/10.7326/0003-4819-115-12-946" @default.
• W2016895314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1824554" @default.
• W2016895314 hasPublicationYear "1991" @default.
• W2016895314 type Work @default.
• W2016895314 sameAs 2016895314 @default.
• W2016895314 citedByCount "23" @default.
• W2016895314 countsByYear W20168953142016 @default.
• W2016895314 crossrefType "journal-article" @default.
• W2016895314 hasAuthorship W2016895314A5024202625 @default.
• W2016895314 hasAuthorship W2016895314A5032053177 @default.
• W2016895314 hasAuthorship W2016895314A5060223419 @default.
• W2016895314 hasAuthorship W2016895314A5062950311 @default.
• W2016895314 hasAuthorship W2016895314A5069644669 @default.
• W2016895314 hasAuthorship W2016895314A5073130519 @default.
• W2016895314 hasAuthorship W2016895314A5084409602 @default.
• W2016895314 hasAuthorship W2016895314A5089633724 @default.
• W2016895314 hasConcept C121608353 @default.
• W2016895314 hasConcept C126322002 @default.
• W2016895314 hasConcept C160160445 @default.
• W2016895314 hasConcept C181199279 @default.
• W2016895314 hasConcept C185592680 @default.
• W2016895314 hasConcept C2776009029 @default.
• W2016895314 hasConcept C2776125364 @default.
• W2016895314 hasConcept C2776694085 @default.
• W2016895314 hasConcept C2779679107 @default.
• W2016895314 hasConcept C2780456651 @default.
• W2016895314 hasConcept C2780496750 @default.
• W2016895314 hasConcept C2992208098 @default.
• W2016895314 hasConcept C526805850 @default.
• W2016895314 hasConcept C55493867 @default.
• W2016895314 hasConcept C71924100 @default.
• W2016895314 hasConcept C90924648 @default.
• W2016895314 hasConceptScore W2016895314C121608353 @default.
• W2016895314 hasConceptScore W2016895314C126322002 @default.
• W2016895314 hasConceptScore W2016895314C160160445 @default.
• W2016895314 hasConceptScore W2016895314C181199279 @default.
• W2016895314 hasConceptScore W2016895314C185592680 @default.
• W2016895314 hasConceptScore W2016895314C2776009029 @default.
• W2016895314 hasConceptScore W2016895314C2776125364 @default.
• W2016895314 hasConceptScore W2016895314C2776694085 @default.
• W2016895314 hasConceptScore W2016895314C2779679107 @default.
• W2016895314 hasConceptScore W2016895314C2780456651 @default.
• W2016895314 hasConceptScore W2016895314C2780496750 @default.
• W2016895314 hasConceptScore W2016895314C2992208098 @default.
• W2016895314 hasConceptScore W2016895314C526805850 @default.
• W2016895314 hasConceptScore W2016895314C55493867 @default.
• W2016895314 hasConceptScore W2016895314C71924100 @default.
• W2016895314 hasConceptScore W2016895314C90924648 @default.
• W2016895314 hasIssue "12" @default.
• W2016895314 hasLocation W20168953141 @default.
• W2016895314 hasLocation W20168953142 @default.
• W2016895314 hasOpenAccess W2016895314 @default.
• W2016895314 hasPrimaryLocation W20168953141 @default.
• W2016895314 hasRelatedWork W1971372102 @default.
• W2016895314 hasRelatedWork W2015140117 @default.
• W2016895314 hasRelatedWork W2016895314 @default.
• W2016895314 hasRelatedWork W2119209082 @default.
• W2016895314 hasRelatedWork W2229919363 @default.
• W2016895314 hasRelatedWork W2368656722 @default.
• W2016895314 hasRelatedWork W2422728978 @default.
• W2016895314 hasRelatedWork W2713402858 @default.

• next